Blood samples were centrifuged at 3000 g for 15 min at ambient temperature to collect supernatant plasma
It is well established that patients with diabetes demonstrate higher susceptibility to pancreatic cancer and pancreatitis compared to non-diabetic individuals, and theoretically, sustained GLP-1 receptor activation induced by GLP-1RA therapy may potentially elevate pancreatic cancer risk [8]
Eder K, Baffy N, Falus A, Fulop AK
Some patients developed severe gastroparesis at just 0.5 mg weekly, while others tolerated higher doses without major complications
Similarly, obesity management requires evidence-based approaches
Follow-up is important, particularly if symptoms worsen after a dose increase or do not respond to conventional tips